Anokion
ID: 5873227Anokion is an immune-tolerated therapeutic proteins founded by Melody Swartz.
2
Funding Rounds
$80.0m
Money raised
Recent Funding Rounds
Overview
Anokion is an immune-tolerated therapeutic proteins founded by Melody Swartz.
- Website:
- Headquarters: Écublens, Vaud
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Me**** Sw**** | - | - | - |
Funding series
Funding Series Analysis
The company Anokion has raised a total of $40m in funding over 2 rounds.
Key Insights:
- Anokion Series B round, September 2019: $40m
- Anokion SA funding round, September 2019: $40m
Industries
Anokion is active in the following industries: